Binding pocket stabilization by high-throughput screening of yeast display libraries
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Molecular Biosciences, 9, Frontiers Media S.A., https://doi.org/10.26083/tuprints-00022911
- Ereignis
-
Veröffentlichung
- (wo)
-
Darmstadt
- (wer)
-
Universitäts- und Landesbibliothek
- (wann)
-
2022
- Urheber
-
Lerma Romero, Jorge A.
Meyners, Christian
Christmann, Andreas
Reinbold, Lisa M.
Charalampidou, Anna
Hausch, Felix
Kolmar, Harald
- DOI
-
10.26083/tuprints-00022911
- URN
-
urn:nbn:de:tuda-tuprints-229113
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lerma Romero, Jorge A.
- Meyners, Christian
- Christmann, Andreas
- Reinbold, Lisa M.
- Charalampidou, Anna
- Hausch, Felix
- Kolmar, Harald
- Universitäts- und Landesbibliothek
Entstanden
- 2022
Ähnliche Objekte (12)
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Streamlining the Transition From Yeast Surface Display of Antibody Fragment Immune Libraries to the Production as IgG Format in Mammalian Cells
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Toward a robust lipid supplementation for SP2/0 fed-batch culture: Improving process performance by leveraging lipoprotein variability
Identification of novel antagonists against skin relevant molecular targets in mediation of itch and inflammation
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Streamlining the Transition From Yeast Surface Display of Antibody Fragment Immune Libraries to the Production as IgG Format in Mammalian Cells
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Toward a robust lipid supplementation for SP2/0 fed-batch culture: Improving process performance by leveraging lipoprotein variability
Identification of novel antagonists against skin relevant molecular targets in mediation of itch and inflammation
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Streamlining the Transition From Yeast Surface Display of Antibody Fragment Immune Libraries to the Production as IgG Format in Mammalian Cells
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Toward a robust lipid supplementation for SP2/0 fed-batch culture: Improving process performance by leveraging lipoprotein variability